LyseNTech completed MTA and CDA with LegoChem Biosciences
관리자 / 2020-08-04
Aug 3, 2020
LyseNTech completed MTA and CDA with LegoChem Biosciences and started a joint study to improve the function of endolysins.
LegoChem Biosciences is a biopharmaceutical company focusing on the development of next generation novel therapeutics utilizing its proprietary medicinal drug discovery technology LegoChemistry™.